Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12356338 | 0.88 | ALDH1A1 (0.55) | ALDH1A1MAPTLMNAKDM4E | |
| SCHEMBL4585596 | 0.87 | ALDH1A1 (0.79) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL677706 | 0.85 | MAPT (0.61) | ALDH1A1MAPTLMNAKDM4EHSD17B10 | |
| SCHEMBL4882223 | 0.84 | MAPT (0.52) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL4878832 | 0.84 | HTT (0.61) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL678892 | 0.83 | PPARG (0.57) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL4586837 | 0.83 | TSHR (0.58) | MAPTMAPK1HSD17B10 | |
| SCHEMBL4593857 | 0.83 | CYP1A2 (0.62) | ALDH1A1MAPTHTTLMNAHPGD | |
| SCHEMBL4585595 | 0.83 | HTT (0.61) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL4586925 | 0.83 | MAPT (0.56) | ALDH1A1MAPTHTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080096848-A1 | N-(2-(1H-Pyrazol-1-yl)-phenyl)-9H-fluorene-1-carboxamide for example; treating proliferative diseases such as cancer, viral diseases, inflammatory bowel disease, rheumatoid arthritis, psoriasis; combination therapy with other known anticancer drugs | CYTOVIA INC. (CA) | 2008-04-24 | — | — | US | claimed |
| EP-1804786-A4 | SUBSTITUTED N-ARYL-9-OXO-9H-FLUORENE-1-CARBOXAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS | CYTOVIA INC (US) | 2008-01-02 | — | — | EP | claimed |
| EP-1804786-A2 | SUBSTITUTED N-ARYL-9-OXO-9H-FLUORENE-1-CARBOXAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS | Cytovia, Inc. (US) | 2007-07-11 | — | — | EP | claimed |
| WO-2006039356-A2 | SUBSTITUTED N-ARYL-9-OXO-9H-FLUORENE-1-CARBOXAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS | CYTOVIA, INC. (US) | 2006-04-13 | — | — | WO | claimed |
| US-9796676-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20160251312-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2016-09-01 | — | — | US | disclosed |
| US-9357781-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2014-11-06 | — | — | US | disclosed |
| WO-2014179785-A1 | IMPROVED HONEYBEE REPELLENTS AND USES THEREOF | INSCENT, INC. (US) | 2014-11-06 | — | — | WO | disclosed |
| US-20080096848-A1 | N-(2-(1H-Pyrazol-1-yl)-phenyl)-9H-fluorene-1-carboxamide for example; treating proliferative diseases such as cancer, viral diseases, inflammatory bowel disease, rheumatoid arthritis, psoriasis; combination therapy with other known anticancer drugs | CYTOVIA INC. (CA) | 2008-04-24 | — | — | US | disclosed |
| EP-1804786-A4 | SUBSTITUTED N-ARYL-9-OXO-9H-FLUORENE-1-CARBOXAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS | CYTOVIA INC (US) | 2008-01-02 | — | — | EP | disclosed |
| EP-1804786-A2 | SUBSTITUTED N-ARYL-9-OXO-9H-FLUORENE-1-CARBOXAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS | Cytovia, Inc. (US) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006039356-A2 | SUBSTITUTED N-ARYL-9-OXO-9H-FLUORENE-1-CARBOXAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS | CYTOVIA, INC. (US) | 2006-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096848-A1 | N-(2-(1H-Pyrazol-1-yl)-phenyl)-9H-fluorene-1-carboxamide for example; treating proliferative diseases such as cancer, viral diseases, inflammatory bowel disease, rheumatoid arthritis, psoriasis; combination therapy with other known anticancer drugs | CASP1, CASP9, CASP14 | ALDH1A1 1418/4885MAPT 3946/4885HTT 3535/4885 |
| US-20160251312-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | ALDH1A1 2033/4885MAPT 1877/4885HTT 1395/4885 |
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | ALDH1A1 2033/4885MAPT 1877/4885HTT 1395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.